AN EDITORIAL in the May 1986 issue of this joumal introduced readers to the National Cholesterol Education Program (NCEP). Launched by the National Heart, Lung, and Blood Institute (NHLBI) in November 1985, the NCEP is a nationwide cooperative effort by major medical and health organizations -the American Heart Association prominently among them to reduce the prevalence of elevated blood cholesterol in the United States. The NCEP will seek to achieve this goal by mounting educational initiatives for health professionals and the public to raise their awareness that lowering high cholesterol levels will reduce the risk of heart attacks and to provide guidance on how to go about accomplishing such cholesterol lowering.
One of the most important early fruits of the NCEP is a set of guidelines for the management of high blood cholesterol in adults, due to be released this month. Officially titled the Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP Adult Treatment Panel, for short), the guidelines are a response to a need identified by surveys of physicians conducted by NHLBI in 1983 and 1986 . They showed that physicians were, on the average, waiting until relatively high levels of blood cholesterol were reached before initiating diet and/or drug therapy for their adult patients. The report is directed primarily to health care professionals, especially to physicians, but also to nurses, dietitians, and pharmacists, who will all have to be actively involved in the care of patients with high blood cholesterol. Thereafter, the NIH Consensus Development Conference on "Lowering Blood Cholesterol to Prevent Heart Disease" concluded that (1) elevated blood cholesterol is a major cause of coronary heart disease and (2) lowering elevated cholesterol levels would help prevent coronary heart disease, and recommended in broad policy outlines the treatment of everyone with a blood cholesterol level above the 75th percentile. Now, with the report of the NCEP Adult Treatment Panel, we have for the first time a detailed set of guidelines giving practical advice for dealing with an individual adult patient's cholesterol problem. Both the substance of the guidelines and the process by which they were developed reflect the highly consensual nature of the panel's report. Substantively, the guidelines build on the consensus view that anyone with a serum total cholesterol level at or above 240 mg/dl deserves careful medical evaluation, that a desirable cholesterol level is below 200 mg/dl, and that dietary change is the primary line of treatment for high blood cholesterol. The basic approach reflected in the guidelines is compatible with the recent recommendations of the European Atherosclerosis Society and the British Cardiac Society Working Group on Coronary Disease Prevention, and we are thus witnessing the emergence of a broad international consensus.
In terms of process, the guidelines were developed by a panel of experts representing a variety of disciplines and a range of expertise, including lipidology, cardiology, epidemiology, dietetics and nutrition, nursing, and primary care medicine. December 1987 We are hopeful that the guidelines, together with materials in the physician's kit and supporting activities such as CME modules, will help physicians integrate the detection and treatment of high blood cholesterol into their routine practices. If physicians make reduction of cholesterol levels a standard feature of their activities, much like treatment of hypertension, the guidelines will have made a major contribution to decreasing the still enormous toll of coronary heart disease.
